Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort
Walbi et al., Journal of International Medical Research, doi:10.1177/03000605221090363
Walbi et al., Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic.., Journal of International Medical Research, doi:10.1177/03000605221090363
Apr 2022   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Retrospective RA/SLE patients in Saudi Arabia. Numbers in this paper are contradictory. Figure 1 and the introduction to the results indicate 304 HCQ users, while Table 1 and later in the results shows 207 (arms switched). The subsequent text reporting the ICU results (2 non-HCQ-users, zero HCQ users) suggests that the labels are switched in Figure 2, or possibly just specific results. This study is excluded in meta analysis: unresolved data inconsistency.
Walbi et al., 6 Apr 2022, retrospective, Saudi Arabia, peer-reviewed, 16 authors, study period March 2020 - February 2021.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: Retrospective Clinical Research Report Effect of chronic hydroxychloroquine use on COVID-19 risk in patients with rheumatoid arthritis and systemic lupus erythematosus: a multicenter retrospective cohort Journal of International Medical Research 50(4) 1–13 ! The Author(s) 2022 Article reuse guidelines: sagepub.com/journals-permissions DOI: 10.1177/03000605221090363 journals.sagepub.com/home/imr Ismail A. Walbi1, Hassan A. Albarqi2, Nayef Saleh Alghanim3, Marzooq Abdullah Albadi4, Hesham Mohammed Al Maimouni5,6, Saad Ahmed Alkahtani1, Ali Mohamed Alshabi1, Amer S. Alali7, Faleh Alqahtani8, Amal Hassan Al-Najjar9, Mohammad A Hazzazi6,10, Deemah S Alanazi11, Abdulrahman Abdulaziz Sabei12, Omer S Alsaweed13, Rahaf K Alajra13 and Hussain Alqhtani1 8 1 Department of Clinical Pharmacy, College of Pharmacy, Najran University, Najran, Saudi Arabia 2 Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia 3 Consultant, Rheumatology Department, King Saud Medical City, Riyadh, Saudi Arabia 4 Consultant internist and rheumatologist, Security Forces Hospital Program, Riyadh, Saudi Arabia 5 Consultant, Rheumatology, Division of Rheumatology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia 6 Assistant Professor of Medicine, King Saud Bin Abdulaziz University of Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia 7 Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia 9 Drug & Poison Information Center Supervisor, Security Forces Hospital Program, Riyadh, Saudi Arabia 10 Vitreoretinal Division, Department of Vitreoretinal, King Abdulaziz Medical City, Riyadh, Saudi Arabia 11 Senior Pharmacist, Pharmaceutical Care Services, King Saud Medical City, Riyadh, Saudi Arabia 12 Senior Registrar, Ministry of Health, First Health cluster, Western Riyadh Dental Complex, Periodontic Division, Riyadh, Saudi Arabia 13 Laboratory Services, Security Forces Hospital Program, Riyadh, Saudi Arabia Corresponding author: Hussain Alqhtani, Department of Clinical Pharmacy, College of Pharmacy, Najran University, King Abdulaziz Road P.O. Box 1988, Najran, Saudi Arabia. Email: hmhalqhtani@nu.edu.sa Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). 2 Journal of International Medical Research Abstract Objective: Hydroxychloroquine (HCQ) has been used during the coronavirus disease 2019 (COVID-19) pandemic because of its reported anti-viral activity. This study examined the association of chronic HCQ use with the incidence and complications of COVID-19. Methods: This retrospective cohort study included adults with rheumatoid arthritis and/or systemic lupus erythematosus who visited rheumatology clinics in three tertiary hospitals in Riyadh, Saudi Arabia between January 2019 and December 2020. Patients were categorized into two groups based on HCQ use. Data were obtained from the electronic health record and by..
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit